Literature DB >> 30250965

[What is certain in the treatment of glomerulonephritis?]

J Floege1, P Boor2, M J Moeller3.   

Abstract

Glomerulonephritides essentially all belong to the rare diseases; however, they are the most common cause of end-stage renal disease in young adults. Besides obtaining a specific diagnosis via a renal biopsy, assessing the prognosis constitutes the other essential step in the work-up, since this enables a decision to be made on whether supportive care with relatively few adverse effects is sufficient or whether additional immunosuppressive therapy is required. The latter is discussed focusing on the most common European types of glomerulonephritis: immunoglobulin A nephropathy, membranous glomerulonephritis, minimal change nephropathy and focal segmental glomerulosclerosis.

Entities:  

Keywords:  Focal segmental glomerulosclerosis; IgA nephropathy; Membranous glomerulonephritis; Minimal change nephropathy; Renal biopsy

Mesh:

Year:  2018        PMID: 30250965     DOI: 10.1007/s00108-018-0500-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 2.  The renal risks of smoking.

Authors:  S R Orth; E Ritz; R W Schrier
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

Review 3.  The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?

Authors:  Jürgen Floege
Journal:  Am J Kidney Dis       Date:  2011-08-26       Impact factor: 8.860

Review 4.  The mucosa-kidney axis in IgA nephropathy.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2015-12-30       Impact factor: 28.314

Review 5.  Uric acid and chronic kidney disease: which is chasing which?

Authors:  Richard J Johnson; Takahiko Nakagawa; Diana Jalal; Laura Gabriela Sánchez-Lozada; Duk-Hee Kang; Eberhard Ritz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

6.  Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.

Authors:  William F Clark; Jessica M Sontrop; Shih-Han Huang; Kerri Gallo; Louise Moist; Andrew A House; Meaghan S Cuerden; Matthew A Weir; Amit Bagga; Scott Brimble; Andrew Burke; Norman Muirhead; Sanjay Pandeya; Amit X Garg
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

7.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Authors:  Elion Hoxha; Ursula Kneißler; Gesa Stege; Gunther Zahner; Ina Thiele; Ulf Panzer; Sigrid Harendza; Udo M Helmchen; Rolf A K Stahl
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

8.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

10.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

View more
  2 in total

Review 1.  [Immunoglobulin A nephropathy].

Authors:  C Seikrit; T Rauen; J Floege
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

2.  Identification of Unique Genetic Biomarkers of Various Subtypes of Glomerulonephritis Using Machine Learning and Deep Learning.

Authors:  Jianbo Qing; Fang Zheng; Huiwen Zhi; Hasnaa Yaigoub; Hasna Tirichen; Yaheng Li; Juanjuan Zhao; Yan Qiang; Yafeng Li
Journal:  Biomolecules       Date:  2022-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.